Glycemic Gap Predicts Mortality in a Large Multicenter Cohort Hospitalized With COVID-19

Context: Diabetes or hyperglycemia at admission are established risk factors for adverse outcomes during hospitalization for COVID-19, but the impact of prior glycemic control is not clear. Objective: We aimed to examine the associations between admission variables, including glycemic gap, and adver...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The journal of clinical endocrinology and metabolism 2023-03, Vol.108 (3), p.718
Hauptverfasser:	McDonnell, Marie E, Garg, Rajesh, Gopalakrishnan, Geetha, Mitri, Joanna, Weinstock, Ruth S, Greenfield, Margaret, Katta, Sai, Lebastchi, Jasmin, Palermo, Nadine E, Radhakrishnan, Ramya, Westcott, Gregory P, Johnson, Matthew, Simonson, Donald C
Format:	Artikel
Sprache:	eng
Schlagworte:	Analysis Dextrose Diabetes therapy Glucose Hospital patients Hyperglycemia Hypoglycemic agents Massachusetts Mortality Patient outcomes Prognosis Risk factors Type 2 diabetes
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!